757125

David R. Spigel, M.D. — FEI 3009014758

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 2, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Nashville, TN (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance
756221 CFR 312.60Informed consent